Консенсус керівних настанов з клінічної практики ISPAD 2018 р. Управління діабетом у дітей дошкільного віку
DOI:
https://doi.org/10.30978/UJPE2021-2-35Ключові слова:
Настанови ISPAD; діти дошкільного віку; діабет 1 типуАнотація
-
Посилання
Rubio-Cabezas O, Hattersley AT, Njolstad PR, et al.ISPAD Clinical Practice Consensus Guidelines 2014. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2014;15(suppl 20):47-64.
Antonovsky A. Unraveling the Mystery of Health. Jossery-Bass Inc. Publishers: San Francisco, CA; 1987.
Gruszfeld D, Socha P. Early nutrition and health: short- and longterm outcomes. World Rev Nutr Diet. 2013;108:32-9.
Khadilkar W, Parthasarathy LS, Mallade BB, Khadilkar AV, Chiplonkar SA, Borade AB. Growth status of children and adolescents with type 1 diabetes mellitus. Indian J Endocrinol Metab. 2013;17:1057-60.
Kim MS, Quintos JB. Mauriac syndrome: growth failure and type 1 diabetes mellitus. Pediatr Endocrinol Rev. 2008;5(suppl 4):989-93.
Prado EL, Dewey KG. Nutrition and brain development in early life. Nutr Rev. 2014;72:267-84.
Kuzawa CW, Chugani HT, Grossman LI, et a I. Metabolic costs and evolutionary implications of human brain development. Proc Natl Acad Sei USA. 2014;111:13010-5.
Leonard WR, Snodgrass XI, Robertson ML. Effects of brain evolution on human nutrition and metabolism. Annu Rev Nutr. 2007;27: 311-27.
Brekke E, Morken TS, Sonnewald U. Glucose metabolism and astrocyte-neuron interactions in the neonatal brain. Neurochem Int. 2015;82:33-41.
Caravas J, Wildman DE. A genetic perspective on glucose consumption in the cerebral cortex during human development. Diabetes Obes Metab. 2014;16(suppl l):21-5.
Morris AA. Cerebral ketone body metabolism. J Inherit Metab Dis. 2005;28:109-21.
North am EA, Anderson PJ, Jacobs R, Hughes M, Warne GL, Weither GA. Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care. 2001;24:1541-6.
Ryan CM. Why is cognitive dysfunction associated with the development of diabetes early in life? The diathesis hypothesis. Pediatr Diabetes. 2006;7:289-97.
McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet. 2012;379:2291-9.
Asvold BO, Sand T, Hestad K, Bjorgaas MR. Cognitive function in type 1 diabetic adults with early exposure to severe hypoglycemia: a 16-year follow-up study. Diabetes Care. 2010;33:1945-7.
Schoenle EJ, Schoenle D, Molinari L, Largo RH. Impaired intellectual development in children with type I diabetes: association with HbA (lc), age at diagnosis and sex. Diabetologia. 2002;45:108-14.
Gaudier! PA, Chen R, Greer TF, Holmes CS. Cognitive function in children with type 1 diabetes: a meta-analysis. Diabetes Care. 2008;31:1892-7.
Bullmore E, Sporns О. The economy of brain network organization. Nat Rev Neurosci. 2012;13:336-49.
Giedd JN, Rapoport JL. Structural MRI of pediatric brain development: what have we learned and where are we going? Neuron. 2010;67:728-34.
Bjorgaas MR. Cerebral effects of severe hypoglycemia in young people with type 1 diabetes. Pediatr Diabetes. 2012;13:100-07.
Perantie DC, Koller JM, Weaver PM, et al. Prospectively determined impact of type 1 diabetes on brain volume during development. Diabetes. 2011;60:3006-14.
Ferguson SC, Blane A, Ward law J, et a I. Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care. 2005;28:1431-7.
Mauras N, Mazaika P, Buckingham B, et al. Longitudinal assessment
of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia. Diabetes.2015;64:1770-9.
Lin A, Northam EA, Rankins D, Werther GA, Cameron FJ. Neuropsychological profiles of young people with type 1 diabetes 12 yr after disease onset. Pediatr Diabetes. 2010;11:235-43.
Perantie DC, Lim A, Wu J, et al. Effects of prior hypoglycemia and hyperglycemia on cognition in children with type 1 diabetes mellitus. Pediatr Diabetes. 2008;9:87-95.
Cato MA, Mauras N, Ambrosino J, et al. Cognitive functioning in young children with type 1 diabetes. J Int Neuropsychol Soc. 2014;20:238-47.
Cato MA, Mauras N, Mazaika P, et al. Longitudinal evaluation of cognitive functioning in young children with type 1 diabetes over 18 months. J Int Neuropsychol Soc. 2016;22:293-302.
Delamater AM, de Wit M, McDarby V, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Psychological care of children and adolescents with type 1 diabetes. Pediatr Diabetes. 2014;15(suppl 20):232-44.
Ly TT, Maahs DM, Rewers A, et al.ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and management of hypoglycemia In children and adolescents with diabetes. Pediatr Diabetes. 2014;15(suppl 20):180-92.
Rewers MJ, PIl1ay K, de Beaufort C, et al.ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes. 2014;15(suppl 20):102-14.
American Diabetes Association. Children and Adolescents. Diabetes Care. 2016;39(suppl 1):S86-S93.
Chiang JL, Kirkman MS, Laffel LM, Peters AL, Type 1 Diabetes Sourcebook Authors. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care. 2014;37:2034-54.
NICE (National Institute for Clinical Excellence). Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults. National Institute for Clinical Excellence, 2015.http://www.nice.org.uk/guidance/ngl8. Accessed 18 June 2017
Lange K, Swift P, Pankowska E, Danne T, International Society for Pediatric and Adolescent DiabetesISPAD Clinical Practice Consensus Guidelines 2014. Diabetes education in children and adolescents. Pediatr Diabetes. 2014;15(suppl 20):77-85.
Rosenbauer J, Dost A, Karges В, et al. Improved metabolic control in children and adolescents with type 1 diabetes: a trend analysis using prospective multicenter data from Germany and Austria. Diabetes Care. 2012;35:80-6.
Swift PG, Skinner TC, de Beaufort CE, et al. Target setting in intensive insulin management is associated with metabolic control: the Hvidoere childhood diabetes study group centre differences study 2005. Pediatr Diabetes. 2010;11:271-8.
Cameron FJ, de Beaufort C, Aanstoot HJ, et al. Lessons from the Hvidoere International Study Group on childhood diabetes: be dogmatic about outcome and flexible in approach. Pediatr Diabetes. 2013;14:473-80.
de Beaufort CE, Lange K, Swift PG, et a I. Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009. Pediatr Diabetes. 2013;14:422-8.
Ceriello A, Ihnat MA. “Glycaemic variability”: a new therapeutic challenge in diabetes and the critical care setting. Diabet Med. 2010;27:862-7.
Virk SA, Donaghue КС, Cho YH, et al. Association between HbA1c variability and risk of microvascular complications In adolescents with type 1 diabetes. J Clin Endocrinol Metab. 2016;101:3257-63.
McNeilly AD, McCrimmon RJ. The Scylla and Charybdis of glucose control in childhood type 1 diabetes? Pediatr Diabetes. 2015; 16:235-41.
Shalitin S, Phillip M. Which factors predict glycemic control in children diagnosed with type 1 diabetes before 6.5 years of age? Acta Diabetol. 2012;49:355-62.
Soupal J, Skrha J Jr, Fajmon M, et al. Glycemic variability Is higher In type 1 diabetes patients with microvascular complications irrespective of glycemic control. Diabetes Tecbnol Tber. 2014;16:198-203.
Smart CE, Annan F, Bruno LP, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Nutritional management in children and adolescents with diabetes. Pediatr Diabetes. 2014;15(suppl 20):135-53.
Maahs DM, Hermann JM, Holman N, et al. Rates of diabetic ketoacidosis: International comparison with 49,859 pediatric patients with type 1 diabetes from England, Wales, the U.S., Austria, and Germany. Diabetes Care. 2015;38:1876-82.
DCCT Research Group (Diabetes Control and Complications Trial Research Group). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-86.
Nathan DM, Group DER. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014;37:9-16.
Edge JA, James T, Shine B. Persistent individual tracking within overall improvement in HbA1c in a UK paediatric diabetes clinic over 15 years. Diabet Med. 2010;27:1284-8.
Hofer SE, Raile K, Fröhlich-Reiferer E, et al. Tracking of metabolic control from childhood to young adulthood In type 1 diabetes. J Pediatr. 2014;165:956-961 el-e2.
Danne T, Mortensen HB, Hougaard P, Lynggaard H, Aanstoot HJ, Chiarelli F. Persistent differences among centers over 3 years In glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidovre Study Group. Diabetes Care. 2001;24:1342-7.
Lawes T, Franklin V, Farmer G. HbA1c tracking and bio-psychosocial determinants of glycaemic control in children and adolescents with type 1 diabetes: retrospective cohort study and multilevel analysis. Pediatr Diabetes. 2014;15:372-83.
Samuelsson U, Steineck I, Gubbjornsdottir S. A high mean-HbA1c value 3‒15 months after diagnosis of type 1 diabetes in childhood is related to metabolic control, macroalbuminuria, and retinopathy in early adulthood ‒ a pilot study using two nation-wide population based quality registries. Pediatr Diabetes. 2014;15:229-35.
Diabetes Control and Complications Trial /Epidemiology of Diabetes I, Complications Research Group, Lächln JM, White NH, Hainsworth DP, et al. Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. Diabetes. 2015; 64:631-42.
Lind M, Oden A, Fahlen M, Eliasson B. The shape of the metabolic memory of HbA1c: re-analysing the DCCT with respect to time- dependent effects. Diabetologia. 2010;53:1093-8.
Bailey C, Day C. Glycaemic memory. Br J Diabetes Vase Dis. 2008;8:242-7.
Donaghue КС, Wadwa RP, Dimeglio LA et al. ISPAD Clinical Practice Consensus Guidelines 2014. Microvascular and macrovascular complications in children and adolescents. Pediatr Diabetes. 2014; 15(suppl 20):257-69.
Olsen BS, Sjolie AK, Hougaard P, et al. The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy In patients with type 1 diabetes. J Diabetes Complications. 2004;18:160-4.
Cho YH, Craig ME, Donaghue КС. Puberty as an accelerator for diabetes complications. Pediatr Diabetes. 2014;15:18-26.
Salardi S, Porta M, Maltoni G, et al. Infant and toddler type 1 diabetes: complications after 20 years’ duration. Diabetes Care. 2012;35:829-33.
Donaghue КС, Fung AT, Hing S, et al. The effect of prepubertal diabetes duration on diabetes. Microvascular complications in early and late adolescence. Diabetes Care. 1997;20:77-80.
Holl RW, Lang GE, Grabert M, Heinze E, Lang GK, Debatin KM. Diabetic retinopathy in pediatric patients with type-1 diabetes: effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control. J Pediatr. 1998;132:790-4.
Anderzen J, Samuelsson U, Gudbjornsdottir S, Hanberger L, Akesson K. Teenagers with poor metabolic control already have a higher risk of microvascular complications as young adults. J Diabetes Complications. 2016;30:533-6.
Danne T, Bangstad HJ, Deeb L, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2014;15(suppl 20):115-34.
Hanas R. Reducing injection pain in children and adolescents with diabetes: a review of Indwelling catheters. Pediatr Diabetes. 2004;5:102-11.
Danne T, Battelino T, Jarosz-Chobot P, et al. Establishing glycaemic control with continuous subcutaneous Insulin Infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries. Diabetologia. 2008;51:1594-601.
Phillip M, Battelino T, Rodriguez H, Danne T, Kaufman F. Use of Insulin pump therapy In the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2007;30:1653-62.
DiMeglio LA Boyd SR, Pottorff TM, Cleveland JL, Fineberg N, Eugster EA. Preschoolers are not miniature adolescents: a comparison of insulin pump doses in two groups of children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2004;17:865-70.
Holterhus PM, Bokelmann J, Riepe F, et al. Predicting the optimal basal insulin infusion pattern in children and adolescents on Insulin pumps. Diabetes Care. 2013;36:1507-11.
NIcolajsen T, Samuelsson A, Hanas R. Insulin doses before and one year after pump start: children have a reversed dawn phenomenon. J Diabetes Sei Tecbnol. 2012;6:589-94.
Alemzadeh R, Hoffmann RG, Dasgupta M, Parton E. Development of optimal kids Insulin dosing system formulas for young children with type 1 diabetes mellitus. Diabetes Tecbnol Tber. 2012;14:418-22.
Thalange N, Bereket A, Larsen J, Hiort LC, Peterkova V. Treatment with Insulin detemir or NPH insulin in children aged 2‒5 years with type 1 diabetes mellitus. Pediatr Diabetes. 2011;12:632-41.
Hathout EH, Fujishige L, Geach J, Ischandar M, Maruo S, Mace JW. Effect of therapy with Insulin glargine (lantus) on glycemic control in toddlers, children, and adolescents with diabetes. Diabetes Technol Ther. 2003;5:801-6.
Mianowska B, Fendler W, Tomasik B, Mlynarski W, Szadkowska A. Effect of insulin dilution on lowering glycemic variability in pump- treated young children with Inadequately controlled type 1 diabetes. Diabetes Technol Ther. 2015;17:605-10.
Elleri D, Allen JM, Tauschmann M, et al. Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3‒6 years: comparison between diluted and standard insulin strength. BMJ Open Diabetes Res Care. 2014;2:e000040.
Hanas R, Adolfsson P. Bolus calculator settings in well-controlled prepubertal children using Insulin pumps are characterized by low Insulin to carbohydrate ratios and short duration of insulin action time. J Diabetes Sci Technol. 2017;11(2):247-52.
Andersen AJ, Ostenfeld A, Pipper CB, et al. Optimum bolus wizard settings in Insulin pumps in children with Type 1 diabetes. Diabet Med. 2016;33:1360-5.
Bell KJ, Smart CE, Steil GM, Brand-Miller JC, King B, Wolpert HA. Impact of fat, protein, and glycemic Index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era. Diabetes Care. 2015;38:1008-15.
Smart CE, Ross K, Edge JA, Collins CE, Colyvas K, King BR. Children and adolescents on intensive insulin therapy maintain postprandial glycaemic control without precise carbohydrate counting. Diabet Med. 2009;26:279-85.
Smart CE, King BR, McElduff P, Collins CE. In children using intensive insulin therapy, a 20-g variation in carbohydrate amount significantly impacts on postprandial glycaemia. Diabet Med. 2012;29:e21-e24.
Infant Feeding Guidelines. Australian Government; National Health and Medical Research Council, Canberra, 2012.https://www.nhmrc.gov.au/guidelines-publications/n56. Accessed 18 June 2017
Patton SR, Dolan LM, Powers SW. Mealtime interactions relate to dietary adherence and glycemic control in young children with type 1 diabetes. Diabetes Care. 2006;29:1002-6.
Mann J, Cummings JH, Englyst HN, et al. FAO/WHO scientific update on carbohydrates in human nutrition: conclusions. Eur J Clin Nutr. 2007;61(suppl 1):S132-S137.
Carbohydrates and Health Scientific Advisory Committee on Nutrition, TSO, London; 2015.https://www.gov.uk/government/uploads/system/upIoads/attachment_data/fіIe/445503/SACN_Carbohydrates_and_Health.pdf. Accessed 18 June 2017
Joint FAO/WHO/UNU expert consultation on protein and amino acid requirements in human nutrition. WHO Technical Report Series, No. 935, Geneva, 2002.
Australian Dietary Guidelines Australian Government; National Health and Medical Research Council, Canberra, 2013. https://www.nhmrc.gov.au/guidelines-publications/n55. Accessed 18 June 2017.
-2020 Dietary Guidelines for Americans. 8th ed. U.S. Department of Health and Human Services and U.S. Department of Agriculture, 2015.http://health.gov/dietaryguidelines/2015/ guidelines/. Accessed 18 June 2017.
Integrating nutrition and physical activity. Nordic Nutrition Recommendations 2012. 5th ed, 2014.http://www.livsmedelsverket.se. Accessed 18 June 2017.
Sundberg F, Augustsson M, Forsander G, Cederholm U, Axelsen M. Children under the age of seven with diabetes are increasing their cardiovascular risk by their food choices. Acta Paediatr. 2014;103:404-10.
Patton SR, Dolan LM, Chen M, Powers SW. Dietary adherence and mealtime behaviors in young children with type 1 diabetes on intensive insulin therapy. J Acad Nutr Diet. 2013;113:258-62.
Patton SR, Dolan LM, Powers SW. Does eating during television viewing affect mealtimes in young children with type 1 diabetes mellitus? J Pediatr Nurs. 2013;28:364-8.
Mehta SN, Volkening LK, Quinn N, Laffel LM. intensively managed young children with type 1 diabetes consume high-fat, low-fiber diets similar to age-matched controls. Nutr Res. 2014;34:428-35.
Kaikkonen JE, Mikkila V, Magnussen CG, Juonala M, Viikari JS, Raitakari ОТ. Does childhood nutrition influence adult cardiovascular disease risk? - insights from the Young Finns Study. Ann Med. 2013;45:120-8.
Cooke L. The importance of exposure for healthy eating in childhood: a review. J Hum Nutr Diet. 2007;20:294-301.
DuBose SN, Hermann JM, Tamborlane WV, et al. Obesity in youth with type 1 diabetes in Germany, Austria, and the United States. J Pediatr. 2015;167:627-32 el-e4.
Kapellen TM, Heidtmann В, Bachmann J, et al. Indications for insulin pump therapy in different age groups: an analysis of 1,567 children and adolescents. Diabet Med. 2007;24:836-42.
Islam ST, Abraham A, Donaghue КС, et al. Plateau of adiposity in Australian children diagnosed with type 1 diabetes: a 20-year study. Diabet Med. 2014;31:686-90.
Christian MS, Evans CE, Hancock N, Nykjaer C, Cade JE. Family meals can help children reach their 5 a day: a cross-sectional survey of children’s dietary intake from London primary schools. J Epidemiol Community Health. 2013;67:332-8.
Overby NC, Margeirsdottir HD, Brunborg C, Andersen LF, Dahl- Jorgensen K. The influence of dietary intake and meal pattern on blood glucose control in children and adolescents using intensive insulin treatment Diabeto/ogia. 2007;50:2044-51.
Powers SW, Byars КС, Mitchell MJ, et al. Parent report of mealtime behavior and parenting stress In young children with type 1 diabetes and in healthy control subjects. Diabetes Care. 2002;25:313-8.
Patton SR, Dolan LM, Powers SW. Differences in family mealtime interactions between young children with type 1 diabetes and controls: implications for behavioral intervention. J Pediatr Psychol. 2008;33:885-93.
Patton SR, Piazza-Waggoner C, Modi AC, Dolan LM, Powers SW. Family functioning at meals relates to adherence in young children with type 1 diabetes. J Paediatr Child Health. 2009;45:736-41.
Patton SR, Dolan LM, Powers SW. Dietary adherence and associated glycemic control in families of young children with type 1 diabetes. J Am Diet Assoc. 2007;107:46-52.
Adamson M, Morawska A, Wigginton B. Mealtime duration in problem and non-problem eaters. Appetite. 2015;84:228-34.
Kühl ES, Clifford LM, Stark LJ. Obesity in preschoolers: behavioral correlates and directions for treatment. Obesity. 2012;20:3-29.
Kavey RE, Allada V, Daniels SR, et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2006;114:2710-38.
Telama R, Yang X, Leskinen E, et al. Tracking of physical activity from early childhood through youth into adulthood. Med Sei Sports Exerc. 2014;46:955-62.
Biddle SJ, Pearson N, Ross GM, Braithwaite R. Tracking of sedentary behaviours of young people: a systematic review. Prev Med. 2010;51:345-51.
Trigona B, Aggoun Y, Maggio A, et al. Preclinical noninvasive markers of atherosclerosis In children and adolescents with type 1 diabetes are influenced by physical activity. J Pediatr. 2010;157:533-9.
Hesketh KR, Goodfellow L, Ekelund U, et al. Activity levels in mothers and their preschool children. Pediatrics. 2014;133:e973-e980.
Jago R, Sebire SJ, Edwards MJ, Thompson JL. Parental TV viewing, parental self-efficacy, media equipment and TV viewing among preschool children. Eur J Pediatr. 2013;172:1543-5.
Fisk CM, Crozier SR, Inskip HM, et al. Influences on the quality of young children’s diets: the importance of maternal food choices. Br J Nutr. 2011;105:287-96.
Raynor HA, Van Walleghen EL, Osterholt KM, et al. The relationship between child and parent food hedonics and parent and child food group intake in children with overweight/obesity. J Am Diet Assoc. 2011;111:425-30.
Brage S, Wedderkopp N, Ekelund U, et al. Features of the metabolic syndrome are associated with objectively measured physical activity and fitness in Danish children: the European Youth Heart Study (EYHS). Diabetes Care. 2004;27:2141-8.
Andersen LB, Harro M, Sardinha LB, et al. Physical activity and clustered cardiovascular risk in children: a cross-sectional study (The European Youth Heart Study). Lancet. 2006;368:299-304.
Steele RM, van Sluijs EM, Cassidy A, Griffin SJ, Ekelund U. Targeting sedentary time or moderate- and vigorous-intensity activity: independent relations with adiposity in a population-based sample of 10-y-old British children. Am J Clin Nutr. 2009;90:1185-92.
Ekelund U, Luan J, Sherar LB, et al. Moderate to vigorous physical activity and sedentary time and cardiometabolic risk factors in children and adolescents. JAMA. 2012;307:704-12.
O’Neill JR, Williams HG, Pfeiffer KA, et al. Young children’s motor skill performance: relationships with activity types and parent perception of athletic competence. J Sci Med Sport. 2014;17:607-10.
Beets MW, Bornstein D, Dowda M, Pate RR. Compliance with national guidelines for physical activity in U.S. preschoolers: measurement and interpretation. Pediatrics. 2011;127:658-64.
WHO. Global Recommendations on Physical Activity for Health, Geneva, 2010.http://www.who.int/dietphysicalactivity/factsheet_recommendations/en/. Accessed 18 June 2017.
Tremblay MS, Leblanc AG, Carson V, et al. Canadian Physical Activity Guidelines for the early years (aged 0‒4 years). Appl Physiol Nutr Metab. 2012;37:345-69.
Australian Government, Department of Health. National Physical Activity Recommendations for Children (0‒5 years). 2014. http://www.health.gov.au/internet/main/publishing.nsf/content/health-pubhlth-strateg-phys-act-guidelines#npa05. Accessed 18 June 2017.
Boldemann C, Blennow M, Dal H, et al. Impact of preschool environment upon children’s physical activity and sun exposure. Prev Med. 2006;42:301-8.
Sundberg F, Forsander G, Fasth A, Ekelund U. Children younger than 7 years with type 1 diabetes are less physically active than healthy controls. Acta Paediatr. 2012;101:1164-9.
Jeha GS, Karaviti LP, Anderson B, et al. Continuous glucose monitoring and the reality of metabolic control in preschool children with type 1 diabetes. Diabetes Care. 2004;27:2881-6.
Sundberg F, Forsander G. Detection and treatment efficacy of hypoglycemic events in the everyday life of children younger than 7 years. Pediatr Diabetes. 2014;15:34-40.
Maahs DM, Hermann JM, DuBose SN, et al. Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Aus- trian DPV registries. Diabetologia. 2014;57:1578-85.
Barnard KD, Oliver N, Adolfsson P, Aldred C, Kerr D. Is iatrogenic sleep disturbance worth the effort in Type 1 diabetes? Diabet Med. 2015;32:984-6.
Lindstrom C, Aman J, Norberg AL. Parental burnout in relation to sociodemographic, psychosocial and personality factors as well as disease duration and glycaemic control in children with Type 1 diabetes mellitus. Acta Paediatr. 2011;100:1011-7.
Blackman SM, Raghinaru D, Adi S, et al. Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy. Pediatr Diabetes. 2014;15:564-72.
Tsalikian E, Fox L, Weinzimer S, et al. Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes. Pediatr Diabetes. 2012;13:301-7.
Englert K, Ruedy K, Coffey J, et al. Skin and adhesive issues with continuous glucose monitors: a sticky situation. J Diabetes Sei Techno!. 2014;8:745-51.
Heinemann L, Kamann S. Adhesives used for diabetes medical devices: a neglected risk with serious consequences? J Diabetes Sei Technol. 2016;10:1211-5.
Battelino T, Nimri R, Dove K, Phillip M, Bratina N. Prevention of hypoglycemia with predictive low glucose insulin suspension in children with type 1 diabetes: a randomized controlled trial. Diabetes Care. 2017;40:764-70.
Mack-Fogg JE, Orlowski CC, Jospe N. Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective. Pediatr Diabetes. 2005;6:17-21.
Brink S, Joel D, Laffel L, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Sick day management in children and adolescents with diabetes. Pediatr Diabetes. 2014;15(suppl 20):193-202.
Pankowska E, Skorka A, Szypowska A, Lipka M. Memory of insulin pumps and their record as a source of information about insulin therapy In children and adolescents with type 1 diabetes. Diabetes Technol Ther. 2005;7:308-14.
Sullivan-Bolyai S, Knafl K, Tamborlane W, Grey M. Parents’ reflections on managing their children’s diabetes with insulin pumps. J Nurs Scholarsh. 2004;36:316-23.
Sundberg F, Viberg C, Soderlund T, Forsander G. CGM related skin problems are most common In very young users but not associated with atopy. Pediatr Diabetes. 2015; 16:112 (suppl 21, abstract P157).
Schober E, Rami B. Dermatological side effects and complications of continuous subcutaneous insulin infusion in preschool-age and school-age children. Pediatr Diabetes. 2009;10:198-201.
Wolfsdorf Jl, Allgrove J, Craig ME, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2014;15(suppl 20):154-79.
Johnson SR, Cooper MN, Davis EA, Jones TW. Hypoglycaemia, fear of hypoglycaemia and quality of life in children with type 1 diabetes and their parents. Diabet Med. 2013;30:1126-31.
Barnard K, Thomas S, Royle P, Noyes K, Waugh N. Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review. BMC Pediatr. 2010; 10:50.
O’Connell SM, Cooper MN, Bulsara MK, Davis EA, Jones TW. Reducing rates of severe hypoglycemia in a population-based cohort of children and adolescents with type 1 diabetes over the decade 2000‒2009. Diabetes Care. 2011;34:2379-80.
Cengiz E, Xing D, Wong JC, et al. Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry. Pediatr Diabetes. 2013;14:447-54.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care. 2010;33:1004-8.
Buckingham B, Wilson DM, Lecher T, et al. Duration of nocturnal hypoglycemia before seizures. Diabetes Care. 2008;31:2110-2.
Golicki DT, Golicka D, Groele L, Pankowska E. Continuous Glucose Monitoring System in children with type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetologia. 2008;51:233-40.
Phillip M, Danne T, Shalitin S, et al. Use of continuous glucose monitoring in children and adolescents. Pediatr Diabetes. 2012;13:215-28.
Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med. 2008;25:765-74.
Bergenstal RM, Klonoff DC, Garg SK, et al. Threshold-based insulin- pump interruption for reduction of hypoglycemia. N Engl J Med. 2013;369:224-32.
Ly TT, Nicholas JA, Retterath A, Lim EM, Davis EA, Jones TW. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA. 2013;310:1240-7.
Akesson K, Eriksson E, Fureman A, Gudbjornsdottir S, Hanberger L, Pundziute-Lycka A, et al. Data from the Swedish National Paediatric Diabetes Registry (SWEDIABKIDS). 2015.
McTavish L, Wiltshire E. Effective treatment of hypoglycemia in children with type 1 diabetes: a randomized controlled clinical trial. Pediatr Diabetes. 2011;12:381-7.
Brodows RG, Williams C, Amatruda JM. Treatment of insulin reactions in diabetics. JAMA. 1984;252:3378-81.
Pham-Short A, Donaghue КС, Ambler G, Chan AK, Craig ME. Coeliac disease in type 1 diabetes from 1990 to 2009: higher incidence in young children after longer diabetes duration. Diabet Med. 2012;29:e286-e289.
Cerutti F, Chiarelli F, Lorini R, Meschi F, Sacchetti C. Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes. Diabetes Care. 2004;27:1294-8.
Frohlich-Reiterer EE, Kaspers S, Hofer S, et al. Anthropometry, metabolic control, and follow-up in children and adolescents with type 1 diabetes mellitus and biopsy-proven celiac disease. J Pediatr. 2011;158:589.e2-593.e2.
Kordonouri O, Klingensmith G, Knip M, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Other complications and diabetes- associated conditions in children and adolescents. Pediatr Diabetes. 2014;15(suppl 20):270-8.
Silverstein J, Klingensmith G, Copeland К, et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005;28:186-212.
Dashiff C, Riley BH, Abdullatif H, Moreland E. Parents’ experiences supporting self-management of middle adolescents with type 1 diabetes mellitus. Pediatr Nurs. 2011;37:304-10.
Botello-Harbaum M, Nansel T, Haynie DL, Iannotti RJ, Simons-Morton B. Responsive parenting is associated with improved type 1 diabetes-related quality of life. Child Care Health Dev. 2008;34:675-81.
Kovacs M. Children’s Depression Inventory. North Tonawanda, NY: Multi-Health Systems, Inc.; 1992.
Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measur. 1977;1:385-401.
Varni JW, Burwinkle TM, Jacobs JR, et al. The PedsQL in type 1 and type 2 diabetes: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales and type 1 Diabetes Module. Diabetes Care. 2003;26:631-7.
Markowitz JT, Volkening LK, Butler DA, et al. Re-examining a measure of diabetes-related burden in parents of young people with type 1 diabetes: the Problem Areas in Diabetes Survey-Parent Revised version (PAID-PR). Diabet Med. 2012;29:526-30.
Markowitz JT, Volkening LK, Butler DA, Laffel LM. Youth-perceived burden of type 1 diabetes: problem areas In diabetes survey-pediatric version (PAID-Peds). J Diabetes Sei Technol. 2015;9:1080-5.
Siminerio LM, Albanese-O’Neill A, Chiang JL, et al. Care of young children with diabetes in the child care setting: a position statement of the American Diabetes Association. Diabetes Care. 2014;37:2834-42.
Bratina N, Battelino T. Insulin pumps and continuous glucose monitoring (CGM) in preschool and school-age children: how schools can integrate technology. Pediatr Endocrinol Rev. 2010;7(suppl 3):417-21.
Kumar KM, Saboo B, Rao PV, et al. Type 1 diabetes: awareness, management and challenges: current scenario in India. Indian J Endocrinol Metab. 2015;19:S6-S8.
Willi SM, Miller KM, DiMeglio LA, et al. Racial-ethnic disparities in management and outcomes among children with type 1 diabetes. Pediatrics. 2015;135:424-34.
Kamps JL, Hempe JM, Chalew SA. Racial disparity in A1C independent of mean blood glucose In children with type 1 diabetes. Diabetes Care. 2010;33:1025-7.
Parrinello CM, Sharrett AR, Maruthur NM, et al. Racial differences in and prognostic value of biomarkers of hyperglycemia. Diabetes Care. 2016;39:589-95.
Rotchford AP, Rotchford KM, Machattie T, Gill GV. Assessing diabetic control - reliability of methods available in resource poor settings. Diabet Med. 2002;19:195-200.
Daneman D, Frank M, Perlman K, Wittenberg J. The infant and toddler with diabetes: challenges of diagnosis and management. Pediatr Child Health. 1999;4:57-63.
